Insider · CIK 0001389147
Stephen George Dilly
Files at CDXS (CODEXIS, INC.). First filing -, latest -.
Stephen George Dilly files SEC Form 4 as officer and director at CDXS (CODEXIS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Stephen George Dilly has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | CDXS CODEXIS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +66,350 | $0.00 | $0 | 66,350 | Jun 18, 2026 |
| Nov 11, 2025 | CDXS CODEXIS, INC. | AGrant or award Common Stock | +50,000 | $1.85 | $92k | 727,053 | Nov 12, 2025 |
| Feb 5, 2025 | CDXS CODEXIS, INC. | AGrant or award Common Stock | +88,750 | $0.00 | $0 | 673,053 | Feb 7, 2025 |
| Feb 5, 2025 | CDXS CODEXIS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +532,500 | $0.00 | $0 | 532,500 | Feb 7, 2025 |
Questions about Stephen George Dilly
Answered from the filings on this page, as of the latest one.
Is Stephen George Dilly buying or selling?
Stephen George Dilly has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Stephen George Dilly's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stephen George Dilly has 0.
Where does Stephen George Dilly file Form 4?
Stephen George Dilly has filed Form 4 at CDXS (CODEXIS, INC.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.